CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF BRAIN METASTASIS FROM BREAST CANCER

Stock Information for vTv Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.